All publications

Export 168 results:
Author Title Type [ Year(Asc)]
Stirrup OT, Sabin CA, Phillips AN, Williams I, Churchill D, Tostevin A, Hill T, Dunn DT, UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort Study.  2019.  Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV.. J Virus Erad. 5(4):204-211.
Le Vu S, Ratmann O, Delpech V, Brown AE, O Gill N, Tostevin A, Dunn D, Fraser C, Volz E.  2019.  HIV-1 transmission patterns in men who have sex with men: insights from genetic source attribution analysis.. AIDS Res Hum Retroviruses.
Stirrup O, Asboe D, Pozniak A, Sabin C, Gilson R, Mackie N, Dunn D, Cohort UKHIVDrug R.  2019.  Use of emtricitabine or lamivudine following detection of the M184V/I HIV-1 resistance mutation. 23rd International Workshop on HIV and Hepatitis Observational Databases.
Mbisa JL, Kirwan P, Tostevin A, Ledesma J, Bibby DF, Brown A, Myers R, Hassan AS, Murphy G, Asboe D et al..  2018.  Determining the origins of HIV-1 drug-resistant minority variants in people who are recently infected using phylogenetic reconstruction.. Clin Infect Dis.
Lodi S, Günthard HF, Dunn DT, Garcia F, Logan R, Jose S., Bucher HC, Scherrer AU, Schneider M-P, Egger M et al..  2018.  Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.. AIDS. 32(3):327-335.
Stirrup OT, Dunn DT.  2018.  Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates.. BMC Med Res Methodol. 18(1):65.
Volz EM, Le Vu S, Ratmann O, Tostevin A, Dunn D, Orkin C, O'Shea S, Delpech V, Brown A, Gill N et al..  2018.  Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control.. J Infect Dis. 217(10):1522-1529.
Ragonnet-Cronin M, Hué S, Hodcroft EB, Tostevin A, Dunn D, Fawcett T, Pozniak A, Brown AE, Delpech V, Brown AJLeigh.  2018.  Non-disclosed men who have sex with men in UK HIV transmission networks: phylogenetic analysis of surveillance data.. Lancet HIV. 5(6):e309-e316.
Stirrup O, Dunn D.  2018.  Novel methodology to evaluate associations between baseline characteristics, CD4 response and viral failure on first-line ART for HIV. 22nd International Workshop on HIV and Hepatitis Observational Databases.
Tostevin A, Stirrup OT, Mackie N, Asboe D, Pozniak A, Churchill D, Leigh Brown A, Sabin C, Smit E, Collins S et al..  2018.  Results of HIV-1 drug resistance tests performed in ART-experienced patients in the UK: patterns 2008 to 2015. BHIVA Spring.
Stirrup OT, Dunn DT, Tostevin A, Sabin CA, Pozniak A, Asboe D, Cox A, Orkin C, Martin F, Cane P.  2018.  Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data.. AIDS Res Ther. 15(1):11.
Geretti AM, White E, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin C, Dunn DT.  2018.  Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance.. J Antimicrob Chemother.
Hodcroft E, Ragonnet-Cronin M, Wertheim JO, Lycett S, Kosakovsky Pond SL, Leigh Brown A.  2017.  Analyzing "missing men" in the UK Heterosexual HIV epidemic by DSPS-HIV simulations. CROI.
Schultze A, Paredes R, Sabin CA, Phillips AN, Pillay D, Mackie N, Castagna A, Chadwick D, Falconer K, Geretti AM et al..  2017.  The association between detected drug resistance mutations and CD4+ T-cell decline in HIV-positive individuals maintained on a failing treatment regimen.. Antivir Ther.
Smit E, White E, Clark D, Churchill D, Zhang H, Collins S, Pillay D, Sabin CA, Nelson M, Winston A et al..  2017.  An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs. J Antimicrob Chemother.
Collins IJ, Foster C, Tostevin A, Tookey P, Riordan A., Dunn DT, Gibb DM, Judd A.  2017.  Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland. Clin Infect Dis. Epub ahead of print
Stirrup O, Dunn D.  2017.  Combining ambiguous nucleotide calls with longitudinal CD4 counts and viral load measurements to derive patient-specific distributions for date of HIV seroconversion. 21st International Workshop on HIV and Hepatitis Observational Databases.
Le Vu S, Ratmann O, Delpech V, Brown A, Gill NO, Tostevin A, Fraser C, Volz E.  2017.  Comparison of cluster-based and source-attribution methods for estimating transmission risk using large HIV sequence databases.. Epidemics.
Mulka L, Ragonnet-Cronin M, Tostevin A, Dunn DT, Leigh Brown A.  2017.  Identifying the sources of recent HIV infection in a UK cohort. 24th International HIV Dynamics and Evolution.
Ragonnet-Cronin M, Hue S, Tostevin A, Pozniak A, Fawcett T, Brown A, Dunn DT, Leigh Brown A.  2017.  Nondisclosed MSM link together in HIV transmission networks. CROI.